IRulya Therapeutics Inc.: insider trading
197 trades by 24 directors, officers and 10% owners since 2019, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$174 K
1 sale by 1 insider
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (24)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| John MilitelloChief Financial Officer | 80,000 | — | — | |
| Luca BenattiDirector | 39,179 | — | $174 K | |
| Dirk ThyeCEO and CMO, Director | 255,000 | — | — | |
| Brendan HannahCBO, COO & CCO | 361,827 | — | — | |
| Charles S. RyanPresident | 130,009 | — | — | |
| David LamondDirector | 2.30 M | — | — | |
| Margaret McLoughlinDirector | 8,000 | — | — | |
| Ted MonohonChief Accounting Officer & VP | 27,440 | — | — | |
| Caryn Gordon McDowellChief Legal & Adm. Officer | 122,500 | — | — | |
| Leslie HolsingerEVP, Preclinical Development | 148,080 | — | — | |
| Karen L. SmithChief Medical Officer | 194,690 | — | — | |
| Philip S. LowDirector | 455,309 | — | — | |
| Christopher P. LoweInterim CEO, COO & CFO | 265,000 | — | — | |
| Michael J. DetkeChief Medical Officer | 140,000 | — | — | |
| Casey LynchChief Executive Officer, Director | 109,895 | — | — | |
| Stephen S. DominyChief Scientific Officer, Director | — | — | — | |
| Chad BoedingManaging Member of Managing Me | 2.84 M | — | — | |
| Pfizer Strategic Investment Holdings LLC10% owner | 2.88 M | — | — | |
| EPIQ Capital Group, LLCIA/Managing Member of 10% owne | 2.85 M | — | — | |
| Christine Lamond10% owner | — | — | — | |
| Kevin YoungDirector | 30,000 | — | — | |
| Pfizer Ventures (US) LLC10% owner | 3.25 M | — | — | |
| Takeda Pharmaceutical Co LTD10% owner | 2.68 M | — | — | |
| Una S. RyanDirector | — | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Dirk ThyeCEO AND CHIEF MEDICAL OFFICER, Director | Buy | +77,000 | $0.700 | $54 K | 843,941 | Form 4 |
| filed | Dirk ThyeCEO AND CHIEF MEDICAL OFFICER, Director | Buy | +77,500 | $0.690 | $53 K | 766,941 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +2,280 | $0.610 | $1 K | 267,975 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +5,000 | $0.620 | $3 K | 272,975 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +23,565 | $0.630 | $15 K | 296,540 | Form 4 |
| filed | Charles S. RyanPRESIDENT | Buy | +48,387 | $0.650 | $31 K | 122,461 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +2,500 | $0.610 | $2 K | 262,271 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +3,424 | $0.600 | $2 K | 265,695 | Form 4 |
| filed | Brendan HannahCHIEF BUSINESS OFFICER AND COO | Buy | +2,155 | $0.580 | $1 K | 259,771 | Form 4 |
| filed | David LamondDirector | Buyindirect | +22,627 | $1.040 | $24 K | 2.35 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +22,627 | $1.000 | $23 K | 2.32 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +300 | $1.000 | $300 | 2.28 M | Form 4 |
| filed | David LamondDirector | Buy | +22,327 | $1.020 | $23 K | 2.30 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +19,123 | $1.010 | $19 K | 2.28 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +19,123 | $1.020 | $20 K | 2.26 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +19,123 | $1.010 | $19 K | 2.24 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +14,378 | $0.940 | $14 K | 2.22 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +14,378 | $0.900 | $13 K | 2.21 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +14,378 | $0.980 | $14 K | 2.19 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +41,026 | $1.320 | $54 K | 2.18 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +41,026 | $1.310 | $54 K | 2.14 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +24,766 | $1.290 | $32 K | 2.10 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +117,348 | $1.290 | $151 K | 2.07 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +107,886 | $1.320 | $142 K | 1.95 M | Form 4 |
| filed | Dirk ThyeChief Executive Officer, Director | Buy | +88,000 | $1.260 | $111 K | 448,911 | Form 4 |
| filed | Dirk ThyeChief Executive Officer, Director | Buy | +80,000 | $1.240 | $99 K | 360,911 | Form 4 |
| filed | Margaret McLoughlinDirector | Buy | +8,000 | $1.230 | $10 K | 8,000 | Form 4 |
| filed | Brendan HannahChief Business Officer | Buy | +71,762 | $1.220 | $88 K | 201,555 | Form 4 |
| filed | Stephen S. DominyChief Scientific Officer, Director | Buyindirect | +763 | $14.40 | $11 K | 1.22 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +50,000 | $33.77 | $1.7 M | 1.85 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +16,621 | $34.28 | $570 K | 1.76 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +13,310 | $35.00 | $466 K | 1.78 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +15,969 | $36.34 | $580 K | 1.79 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +4,100 | $36.86 | $151 K | 1.80 M | Form 4 |
| filed | Chad BoedingManaging Member of Managing Me | Buyindirect | +2,440 | $44.06 | $108 K | 2.86 M | Form 4 |
| filed | Chad BoedingManaging Member of Managing Me | Buyindirect | +6,600 | $44.32 | $293 K | 2.86 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +13,609 | $42.13 | $573 K | 1.71 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +10,642 | $43.32 | $461 K | 1.72 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +24,874 | $43.88 | $1.1 M | 1.75 M | Form 4 |
| filed | Chad BoedingManaging Member of 10% Owner | Buyindirect | +2,085 | $55.90 | $117 K | 2.85 M | Form 4 |
| filed | Chad BoedingManaging Member of 10% Owner | Buyindirect | +520 | $55.80 | $29 K | 2.85 M | Form 4 |
| filed | Chad BoedingManaging Member of 10% Owner | Buyindirect | +5,668 | $58.00 | $329 K | 2.85 M | Form 4 |
| filed | Chad BoedingManaging Member of 10% Owner | Buyindirect | +417 | $57.22 | $24 K | 2.85 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +400 | $54.09 | $22 K | 1.66 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +5,906 | $55.42 | $327 K | 1.67 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +32,894 | $56.42 | $1.9 M | 1.70 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +1,263 | $46.30 | $58 K | 1.65 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +985 | $48.37 | $48 K | 1.66 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +1,600 | $48.96 | $78 K | 1.66 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +1,000 | $50.71 | $51 K | 1.66 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +500 | $52.20 | $26 K | 1.66 M | Form 4 |
| filed | David LamondDirector | Buyindirect | +100 | $53.10 | $5 K | 1.66 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyindirect · amended | +420 | $24.87 | $10 K | 2.85 M | Form 4/A |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyamended | +1,635 | $24.87 | $41 K | 2.85 M | Form 4/A |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buyindirect | +420 | $24.87 | $10 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buy | +1,635 | $24.87 | $41 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyindirect · amended | +600 | $25.69 | $15 K | 2.84 M | Form 4/A |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyamended | +2,310 | $25.69 | $59 K | 2.85 M | Form 4/A |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buyindirect | +600 | $25.69 | $15 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buy | +2,310 | $25.69 | $59 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyindirect · amended | +2,100 | $26.50 | — | 2.84 M | Form 4/A |
| filed | Chad BoedingManaging Member of IA | Buyindirect | +2,100 | $26.50 | $56 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member of 10% owne | Buyindirect · amended | +700 | $26.37 | — | 2.84 M | Form 4/A |
| filed | Chad BoedingManaging Member of IA | Buyindirect | +700 | $26.37 | $18 K | 2.83 M | Form 4 |
| filed | Una S. RyanDirector | Buyindirect | +2,875 | $17.00 | $49 K | 2,875 | Form 4 |
| filed | Kevin YoungDirector | Buy | +30,000 | $17.00 | $510 K | 30,000 | Form 4 |
| filed | Margaret McLoughlinDirector | Buy | +550 | $17.00 | $9 K | 550 | Form 4 |
| filed | Pfizer Ventures (US) LLC10% owner | Buy | +50,000 | $17.00 | $850 K | 3.25 M | Form 4 |
| filed | Chad BoedingManaging Member of Managing Me | Buyamended | +4,350 | $26.41 | — | 2.84 M | Form 4/A |
| filed | Chad BoedingManaging Member of Managing Me | Buyindirect · amended | +4,170 | $27.58 | — | 2.84 M | Form 4/A |
| filed | Chad BoedingManaging Member of Managing Me | Buyindirect · amended | +80 | $27.05 | — | 2.84 M | Form 4/A |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buy | +4,350 | $26.41 | $115 K | 2.82 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buyindirect | +4,170 | $27.58 | $115 K | 2.83 M | Form 4 |
| filed | EPIQ Capital Group, LLCIA/Managing Member 10% owner | Buyindirect | +80 | $27.05 | $2 K | 2.83 M | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice